Clinical Trial Update: Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing eribulin to vinorelbine in locally recurrent or metastatic breast cancer after anthracycline and taxane treatment has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Eribulin (eribulin mesilate)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: HER2-Negative Breast Cancer, Triple Negative Breast Cancer | Phase 3 | Status: COMPLETED